Zhejiang Medicines & Heal · 66-66 · CHINA
For Zhejiang Medicines & Heal, import alert is 66-66; country is CHINA; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Doxorubicin HCl | Daunorubicin HCl | Mitomycin; product code is 56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf | 56 H - S 25 Daunorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf | 56 H - S 45 Mitomycin (Antitumor), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 7 Tianmushan Road , Hangzhou, Zhejiang CHINA, verified against its source on 2026-09-30.
- Firm
- Zhejiang Medicines & Heal verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- CHINA verified
- Address
- 7 Tianmushan Road , Hangzhou, Zhejiang CHINA verified
- Date published
- 09/30/2009 verified
- Product code
- 56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf | 56 H - S 25 Daunorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf | 56 H - S 45 Mitomycin (Antitumor), Active Pharm Ingred/Chems for Further Manuf each item verified
- Product
- Doxorubicin HCl | Daunorubicin HCl | Mitomycin each item verified
- FDA notes
- 10/10/2000 | 10/10/2000 | J0/10/2000 each item verified
What the source says
Zhejiang Medicines & Heal Date Published : 09/30/2009 7 Tianmushan Road , Hangzhou, Zhejiang CHINA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/25/2019 Desc: Doxorubicin HCl Notes: 10/10/2000 56 H - S 25 Daunorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/25/2019 Desc: Daunorubicin HCl Notes: 10/10/2000 56 H - S 45 Mitomycin (Antitumor), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/25/2019 Desc: Mitomycin Notes: J0/10/2000
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html